Donald B. Rice
Director/Board Member at Nammi Therapeutics, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Robert Bradway | M | 61 | 18 years | |
| Thompson Baker | M | 66 | 17 years | |
| David Stover | M | - |
Nammi Therapeutics, Inc.
 Nammi Therapeutics, Inc. BiotechnologyHealth Technology Nammi Therapeutics, Inc. specializes in prodrug design that allows for efficient and stable incorporation into nammisomes. The American company's technology maintains immune modulating agents in an inactive state until released by intracellular esterases, and provides IP and FTO. The private company was founded by David Stover. David Stover has been the CEO since incorporation. | - |
| Jerry Perkins | M | 54 | 22 years | |
| Lee Styslinger | M | 63 | 11 years | |
| Mary Carlisle | F | 43 | 18 years | |
| Esteban Santos | M | 56 | 17 years | |
| David Reese | M | 61 | 19 years | |
| Cynthia Hostetler | F | 60 | 10 years | |
| Joseph Rice | M | 59 |
Nammi Therapeutics, Inc.
Nammi Therapeutics, Inc. BiotechnologyHealth Technology Nammi Therapeutics, Inc. specializes in prodrug design that allows for efficient and stable incorporation into nammisomes. The American company's technology maintains immune modulating agents in an inactive state until released by intracellular esterases, and provides IP and FTO. The private company was founded by David Stover. David Stover has been the CEO since incorporation. | 9 years |
| O. Hall | M | 66 | 10 years | |
| Matthew Busch | M | 50 | 20 years | |
| Robert Eckert | M | 69 | 21 years | |
| James Prokopanko | M | 70 | 15 years | |
| Martha E. Vincent | M | - |
Agensys, Inc.
 Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA. | 29 years |
| Richard O'Brien | M | 70 | 16 years | |
| Thomas Fanning | M | 66 | 9 years | |
| Kyle Hranicky | M | - | 29 years | |
| Scott Primeau | M | - | 16 years | |
| Janet F. Kavinoky | F | - | 9 years | |
| Randy Pigg | M | 51 | 19 years | |
| Stanley Bass | M | 62 | 28 years | |
| John Campbell | M | - | 29 years | |
| Lindsay T. Lewellen | M | - | 23 years | |
| Mark D. Warren | M | - | 24 years | |
| Sidney F. Mays | M | 61 | 38 years | |
| C. Wes Burton | M | 57 | 13 years | |
| Derek Miller | M | - | 21 years | |
| George M. Ayoub | M | - |
Nammi Therapeutics, Inc.
Nammi Therapeutics, Inc. BiotechnologyHealth Technology Nammi Therapeutics, Inc. specializes in prodrug design that allows for efficient and stable incorporation into nammisomes. The American company's technology maintains immune modulating agents in an inactive state until released by intracellular esterases, and provides IP and FTO. The private company was founded by David Stover. David Stover has been the CEO since incorporation. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Timothy Sloan | M | 63 | 32 years | |
| Donald James | M | 75 | 23 years | |
| Paul M. Hazen | M | 82 | 14 years | |
| Kathryn Falberg | F | 63 | 6 years | |
| John Baker | M | 74 | 13 years | |
| Kevin A. Rhein | M | 70 | 7 years | |
| William P. Rutledge | M | 82 |
Teledyne, Inc.
 Teledyne, Inc. Other Metals/MineralsNon-Energy Minerals Teledyne, Inc. is a technology-based manufacturing businesses. It is engaged in serving customers with specialty metals for consumer, industrial and aerospace applications; commercial and government-related aviation and electronics products and consumer and industrial products. The company was founded by Henry Singleton and George Kozmetsky in 1960 and is headquartered in Akron, OH. | 3 years |
| Stephen W. Sanger | M | 78 | 14 years | |
| Dick M. Kovacevich | M | 80 | 11 years | |
| Danny Shepherd | M | 73 | 14 years | |
| Michael Kelly | M | 67 | 14 years | |
| John Stumpf | M | 69 | 14 years | |
| David W. Beier | M | 75 | 10 years | |
| Paul Eisenberg | M | - | 14 years | |
| Patricia R. Callahan | F | 70 | 22 years | |
| Avid Modjtabai | F | 62 | 27 years | |
| Jean-Pierre Murray | M | 56 |
Pepperdine University
| 4 years |
| Yuan Da Zhang | M | - | - | |
| William P. Sheridan | M | 69 | 5 years | |
| Cynthia Flowers | F | 64 | 5 years | |
| William Ashton | M | 73 | 16 years | |
| James H. Rowe | M | - | 13 years | |
| Jacob Susman | M | - | 2 years | |
| John Smither | M | 71 | 6 years | |
| James Daly | M | 63 | 9 years | |
| John Moriarty | M | 56 | 6 years | |
| Preston Klassen | M | 55 | 7 years | |
| Jenny Tanujaya | F | 59 |
Pepperdine University
| 6 years |
| David Kreuter | M | - |
University of Notre Dame
| 7 years |
| Sean E. Harper | M | 61 | 16 years | |
| John McPherson | M | 56 | 7 years | |
| Gregory L. Tewalt | M | - | - | |
| Michael Severino | M | 58 | 10 years | |
| Tom C. Gores | M | - |
University of Notre Dame
| 7 years |
| Vasant Prakash Gandhi | M | - | 5 years | |
| Craig Shepherd | M | - | 7 years | |
| Cynthia Patton | F | 62 | 15 years | |
| Thomas Zindrick | M | 65 | 8 years | |
| Willard Dere | M | 70 | 11 years | |
| Erin Lavelle | F | 46 | 15 years | |
| David Quint | M | 74 |
University of Notre Dame
| 7 years |
| Leonard Schaeffer | M | 78 | 9 years | |
| Charles J. Dougherty | M | 75 |
University of Notre Dame
| 2 years |
| Anna Richo | F | 63 | - | |
| Elaine Chao | F | 71 | 2 years | |
| George Morrow | M | 72 | 10 years | |
| Brian M. McNamee | M | 67 | - | |
| Vincent J. Trosino | M | 82 | 14 years | |
| Arie Belldegrun | M | 74 |
Agensys, Inc.
Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA. | 11 years |
| Kathleen Wilson-Thompson | F | 66 | 9 years | |
| William J. Schmuhl | M | 80 |
University of Notre Dame
| 6 years |
| Dominique Monnet | M | 65 | 11 years | |
| Carl E. Reichardt | M | 93 | 11 years | |
| Judith M. Runstad | F | 79 | 18 years | |
| Richard D. McCormick | M | 83 | 28 years | |
| Susan Swenson | F | 75 | 23 years | |
| Roberto Pedro Rosenkranz | M | 74 |
Scios, Inc.
 Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | 1 years |
| Christopher D. Davies | M | 58 | 18 years | |
| John Lewicki | M | 72 |
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | 17 years |
| Susan E. Engel | F | 77 | 19 years | |
| J. Reason | M | 83 | 12 years | |
| Sean C. O'Keefe | M | 68 |
US Department of Defense (District of Columbia)
| - |
| Nicholas G. Moore | M | 82 | 7 years | |
| Tom McIntyre | M | - |
University of Notre Dame
| 6 years |
| Barry X. Lynn | M | - | 16 years | |
| Jean-Jacques Murray | M | 57 |
Pepperdine University
| 6 years |
| Frank J. Biondi | M | 79 | 15 years | |
| Dan Sansone | M | 71 | 26 years | |
| Kevin M. Butler | M | 68 |
University of Notre Dame
| 6 years |
| Paul E. Knauss | M | - |
University of Notre Dame
| 6 years |
| David Berman | M | - | 27 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Donald B. Rice
- Personal Network
